24 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
reputation for quality, their industry leadership and our shared commitment to develop innovative life science tools. We remain committed to our … and therapeutic applications. MyChem develops integrated partnerships with customers across the globe to provide premium reagents and innovative services
DRSLTR
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
14 Oct 20
Correspondence regarding draft registration statement
12:00am
are a leading life sciences company, a leader in many aspects of the market segments in which you operate, that your products present innovative solutions … products stand out when compared to our competitors because they present innovative solutions to customer needs, as indicated by the responses
UPLOAD
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 Oct 20
Letter from SEC
12:00am
products present
innovative solutions, and that you believe your HCP ELISAs have
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
to commercialization.
Awards and Recognitions:
Maravai was recognized in Fast Company’s most innovative companies in biotech list for the Cygnus
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
that Vector has been part of Maravai,” said Hull. “During that time, we brought in Dr. Sellers to lead the team and launched a number of innovative
PRE 14A
9julb17y
9 Apr 21
Preliminary proxy
4:16pm
DEF 14A
b90kbzo4d
19 Apr 21
Definitive proxy
4:46pm
DRS
ssvcq795pjrujubj
8 Sep 20
Draft registration statement
12:00am
424B4
fcukhprp2wj
9 Apr 21
Prospectus supplement with pricing info
4:02pm
424B4
u93mnye ttx0
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS/A
f0o94bm2
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
v49bb02fqj8ocn5l1
14 Oct 20
Draft registration statement (amended)
12:00am
DRS
ibefs w0gsp3uhrf
25 Mar 21
Draft registration statement
12:00am
S-1
lxjaeq
29 Oct 20
IPO registration
5:04pm
10-Q
lbr3uh9util7dnfopru
12 May 21
Quarterly report
4:26pm